Sahyadri College of Pharmacy Solapur Courses & Fees 2025
Sahyadri College of Pharmacy Solapur Fees & Eligibility
Sahyadri College of Pharmacy Solapur has released the fees for the academic year 2021-2022. Sahyadri College of Pharmacy Solapur UG Fees in year 2021 is Rs 3.6 Lakhs. Sahyadri College of Pharmacy Solapur PG Fees in year 2021 is Rs 2 Lakhs.
Sahyadri College of Pharmacy Solapur top courses include Master of Pharmacy [M.Pharm] (Pharmaceutical Chemistry), Diploma in Pharmacy [D.Pharm], B.Pharm. Sahyadri College of Pharmacy Solapur Master of Pharmacy [M.Pharm] (Pharmaceutical Chemistry) Fees in year 2021 is Rs 2 Lakhs, Diploma in Pharmacy [D.Pharm] Fees is Rs 1.4 Lakhs, B.Pharm Fees is Rs 3.6 Lakhs for entire course duration.
| Course | Fees | Eligibility | Application Date | Action |
|---|---|---|---|---|
| ₹1 Lakh (1st Year Fees) | Graduation | - | ||
| ₹70,000 (1st Year Fees) | 12th | - | ||
| ₹90,000 (1st Year Fees) | 12th | 16 Jan - 01 Mar 2024 |
Do you think the Course details are wrong ? Report Here
Courses Offered By Sahyadri College of Pharmacy Solapur 2025
Select Degree and Streams to See Course Fees and Admission Details.
Eligibility:
Application Date:
Do you think the fees are wrong ? Report Here
Course Finder
Search from 20K+ Courses and 35+ Streams
Popular Streams:
Sahyadri College of Pharmacy Solapur Latest News
Discover More Colleges
![Gandhi Natha Rangji College of D. Pharmacy - [GNRCDP]](https://assets.collegedunia.com/public/college_data/images/appImage/undefined?h=111.44&w=263&mode=stretch)
![Gandhi Natha Rangji College of D. Pharmacy - [GNRCDP]](https://assets.collegedunia.com/public/college_data/images/logos/1601006956unnamed.png?h=72&w=72&mode=stretch)
![Adarsh Shikshan Sanstha's College of Pharmacy-[ASSCP]](https://assets.collegedunia.com/public/college_data/images/logos/1602924984download.jpg?h=72&w=72&mode=stretch)
![Dr RG Bhoyar Institute of Pharmacy - [RGBIP]](https://assets.collegedunia.com/public/college_data/images/logos/1425964763Captureefds.jpg?h=72&w=72&mode=stretch)
SUBSCRIBE TO OUR NEWS LETTER
Comments